Xavant Technology (Pty) Ltd announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the STIMPOD NMS400 nerve stimulator (currently available as the STIMPOD NMS410) used for nerve location during Regional Anesthesia procedures. http://www.xavant.com/home/index.php?ipkArticleID=29 The Stimpod NMS400 recently won a 2009 SABS Design Excellence Award in the medical device category. http://www.xavant.com/home/index.php?ipkArticleID=30 The South African Journal of Regional Anaesthesia features the Stimpod. http://www.xavant.com/home/index.php?ipkArticleID=31 Xavant recently introduced its new range and generation Stimpod NMS410 and 450 nerve stimulators in South Africa and international markets. Sales have exceeded all expectations in the first 60 days since its launch on March 25. Xavant began shipping to Europe in May with initial sales expected from France, Germany, Italy, Spain and the UK. The new generation Stimpod will be available in over 40 EU countries in the coming months. The NMS410 is already available in the USA with the NMS450 to follow within the next few months. http://www.xavant.com/home/index.php?ipkArticleID=34